2:21 PM · 13 October 2023

Novo Nordisk surges after higher Q3 earnings forecasts

Novo Nordisk (NOVOB.DK) shares are gaining 3.0% after the company raised its sales forecast for 2023 on strong demand for Ozempic and Wegovy medicines.

  • Operating profit at constant exchange rates +40% to +46%, previously expected +31% to +37%, Bloomberg estimated +37.5% 
  • Sales at constant exchange rates +32% to +38%, previously expected +27% to +33%, Bloomberg estimated +31.7%.
28 May 2026, 8:05 AM

Orlen beats expectations with its best quarter since 2023 📈

27 May 2026, 2:53 PM

US OPEN: Further records on Wall Street at risk

27 May 2026, 12:58 PM

Market wrap: ASML and Infineon support sentiments in Europe

27 May 2026, 12:51 PM

PDD shares plunge over 7% following earnings report⏰

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits